| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S2000-MELAN, M1d/ BRAF, Enco+Bini+Nivo vs Ipil+Nivo | 1 | Y | 1 Encorafenib/Binimetinib/Nivolu | 35 | 16 | 3 | 2 | 2 | 0 | 0 | 01/06/2021 | 115 | 45 |
| 2 Ipilimumab + Nivolumab | 16 | 1 | 1 | 1 | 0 | 0 | ||||||||
| 32 | 4 | 3 | 3 | 0 | 0 | |||||||||
| Yes | EA6141-Melan, Adv, Nivolumab+Ipi ± Sargmostim | 1 | E | Total Registrations | 60 | 11 | 4 | 1 | 1 | 0 | 03/25/2016 | 238 | 93 | |
| 60 | 11 | 4 | 1 | 1 | 0 | |||||||||
| EA6194-Melan, Stage IIIB-D, Pembro +/- CMP-001 | 1 | E | Total Registrations | 4 | 4 | 4 | 3 | 0 | 0 | 12/22/2023 | 2 | |||
| 4 | 4 | 4 | 3 | 0 | 0 | |||||||||
| No | S2015-MELAN, Stg I-II, 1cm v 2cm excision margins | 1 | E | Total Registrations | 582 | 417 | 190 | 96 | 29 | 5 | 05/12/2022 | 160 | 65 | |
| 582 | 417 | 190 | 96 | 29 | 5 | |||||||||
| A091903-Melan, Resected Mucosal, Adj Nivo +/- Cabo | 0 | E | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 11/01/2022 | 97 | 52 | ||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| 1 | E | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 11/01/2022 | |||||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| EA6174-Merkel, Adjuvant Pembrolizumab vs Observation | 1 | E | Total Registrations | 53 | 0 | 0 | 0 | 0 | 0 | 05/01/2019 | 303 | 104 | ||
| 53 | 0 | 0 | 0 | 0 | 0 | |||||||||
| EA6192-Melan, Adv, Erly Discont of Antibdy Thrpy | 0 | E | Total Registrations | 7 | 0 | 0 | 0 | 0 | 0 | 09/22/2021 | 114 | 49 | ||
| 7 | 0 | 0 | 0 | 0 | 0 | |||||||||
| 1 | E | Total Registrations | 8 | 0 | 0 | 0 | 0 | 0 | 09/22/2021 | |||||
| 8 | 0 | 0 | 0 | 0 | 0 | |||||||||